(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...

(Reuters) - Kohl's on Friday changed the title of its chief DEI officer and broadened its supplier diversity program in ...

The first looks at the new version of Toxic Avenger are here, as well as a brand new poster. The film will be released in ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

U.S. District Judge M. Casey Rodgers, accused in a misconduct complaint two weeks ago of showing preference to women, gave ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

The third episode of Marvel Television's new series Daredevil: Born Again was released earlier this week and is receiving ...

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...